Fractional Exhaled Nitric Oxide (FeNO) Measurements with the NIOX VERO® in Children 4 to 6 Years Old using the 6 and 10 Second Exhalation Modes von Jain, Neal, Wasserman, Richard L., LaForce, Craig F., Anolik, Robert, MacDonald-Berko, Margot, Rickard, Kathleen A.

Volltext

Salmeterol Plus Theophylline Combination Therapy in the Treatment of COPD von ZuWallack, Richard L., Mahler, Donald A., Reilly, Donna, Church, Nina, Emmett, Amanda, Rickard, Kathleen, Knobil, Katharine

Volltext

Salmeterol Powder Provides Significantly Better Benefit Than Montelukast in Asthmatic Patients Receiving Concomitant Inhaled Corticosteroid Therapy von Fish, James E., Israel, Elliot, Murray, John J., Emmett, Amanda, Boone, Rebecca, Yancey, Steven W., Rickard, Kathleen A.

Volltext

Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast von Nelson, Harold S., Busse, William W., Kerwin, Edward, Church, Nina, Emmett, Amanda, Rickard, Kathleen, Knobil, Katharine

Volltext

MISSION ABC: transforming respiratory care through one-stop multidisciplinary clinics – an observational study von Heiden, Emily, Longstaff, Jayne, Chauhan, Milan J A, DeVos, Ruth, Lanning, Ellie, Neville, Daniel, Jones, Thomas Llewelyn, Begum, Selina, Amos, Mark, Mottershaw, Mark, Micklam, Joanne, Holdsworth, Ben, Rupani, Hitasha, Brown, Thomas, Chauhan, Anoop J, Baghammar, Jona, Bannell, Kathryn, Dominey, Rachel, Guile, Robert, Jackson, Richard, Leung, Anthony, Maxwell, Fiona, Meehan, Dave, Moseley, Sara, Pullen, Marcus, Rickard, Kathleen A, Sanders, Mark, Whiteman, Matt

Volltext

Addition of salmeterol to low-dose fluticasone versus higher-dose fluticasone: An analysis of asthma exacerbations von Matz, Jonathan, Emmett, Amanda, Rickard, Kathleen, Kalberg, Christopher

Volltext

ENSIFENTRINE REDUCES COPD SYMPTOMS AND RESCUE MEDICATION USE OVER 24 WEEKS IN TWO PHASE 3 TRIALS IN SYMPTOMATIC PATIENTS WITH MODERATE TO SEVERE COPD von SCIURBA, FRANK C, RHEAULT, TARA, BENGTSSON, THOMAS, ANN RICKARD, KATHLEEN

Volltext

ENSIFENTRINE, A NOVEL DUAL PHOSPHODIESTERASE (PDE) 3 AND 4 INHIBITOR, REDUCES EXACERBATION RATE AND RISK REGARDLESS OF EXACERBATION HISTORY IN POOLED ENHANCE TRIAL ANALYSES von SCIURBA, FRANK C, RHEAULT, TARA, BENGTSSON, THOMAS, ANN RICKARD, KATHLEEN

Volltext

ENSIFENTRINE ADDED TO TIOTROPIUM OVER 4 WEEKS PROVIDES ADDITIONAL IMPROVEMENT IN COPD QUALITY OF LIFE von Rickard, Kathleen, Bengtsson, Thomas, Rheault, Tara

Volltext

ENSIFENTRINE ADDED ON TO TIOTROPIUM SIGNIFICANTLY IMPROVES INSPIRATORY CAPACITY IN PATIENTS WITH SYMPTOMATIC COPD von Rickard, Kathleen, Bengtsson, Thomas, Rheault, Tara

Volltext

ENSIFENTRINE IMPROVED SYMPTOMS AND QUALITY OF LIFE IN PATIENTS WITH MODERATE-TO-SEVERE COPD REGARDLESS OF SMOKING STATUS von STRINGER, WILLIAM W, POLVERINO, FRANCESCA, RHEAULT, TARA, RICKARD, KATHLEEN A, DIXON, AMY, REYNER, DANIEL, CASABURI, RICHARD

Volltext

ENSIFENTRINE IMPROVED SYMPTOMS AND QUALITY OF LIFE IN PATIENTS WITH COPD REGARDLESS OF BRONCHITIS HISTORY von OHAR, JILL A, RHEAULT, TARA, RICKARD, KATHLEEN A, DIXON, AMY, REYNER, DANIEL, DIAZ, ALEJANDRO A

Volltext

ENSIFENTRINE, A NOVEL COPD TREATMENT, REDUCED COPD-RELATED HEALTHCARE RESOURCE UTILIZATION OVER 48 WEEKS von WAN, EMILY, RHEAULT, TARA, DIXON, AMY, REYNER, DANIEL, RICKARD, KATHLEEN A

Volltext

ENSIFENTRINE IMPROVED LUNG FUNCTION, SYMPTOMS, AND QUALITY OF LIFE REGARDLESS OF COPD SEVERITY von BON, JESSICA M, RHEAULT, TARA, RICKARD, KATHLEEN A, DIXON, AMY, REYNER, DANIEL, KUHN, BROOKS T

Volltext

ENSIFENTRINE IMPROVED LUNG FUNCTION IN PATIENTS WITH MODERATE TO SEVERE COPD: A POOLED ANALYSIS FROM THE PHASE 3 ENHANCE TRIALS von MASELLI CACERES, DIEGO J, RHEAULT, TARA, RICKARD, KATHLEEN A, DIXON, AMY, REYNER, DANIEL, LESTER, MICHAEL

Volltext

ENSIFENTRINE, A DUAL PDE 3 AND 4 INHIBITOR, PROVIDES EFFECTIVE BRONCHODILATION IN PATIENTS WITH COPD WHEN ADMINISTERED TWICE DAILY OVER 7 DAYS VIA PMDI von RHEAULT, TARA, SINGH, DAVE, LEAKER, BRIAN, BENGTSSON, THOMAS, RICKARD, KATHLEEN

Volltext

Efficacy of Salmeterol Xinafoate in the Treatment of COPD von Mahler, Donald A., Donohue, James F., Barbee, Robert A., Goldman, Michael D., Gross, Nicholas J., Wisniewski, Michael E., Yancey, Steven W., Zakes, Bradford A., Rickard, Kathleen A., Anderson, Wayne H.

Volltext

Ensifentrine, a Novel Phosphodiesterase 3 and 4 Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease: Randomized, Double-Blind, Placebo-controlled, Multicenter Phas... von Anzueto, Antonio, Barjaktarevic, Igor Z, Siler, Thomas M, Rheault, Tara, Bengtsson, Thomas, Rickard, Kathleen, Sciurba, Frank

Volltext

POOLED SAFETY RESULTS OVER 24 WEEKS FROM THE ENHANCE PROGRAM WITH ENSIFENTRINE, A NOVEL DUAL PHOSPHODIESTERASE (PDE) 3 AND 4 INHIBITOR von SILER, THOMAS M, FOGARTY, CHARLES M, RHEAULT, TARA, BENGTSSON, THOMAS, ANN RICKARD, KATHLEEN

Volltext

NEBULIZED ENSIFENTRINE IMPROVES LUNG FUNCTION, SYMPTOMS, QUALITY OF LIFE AND REDUCES EXACERBATIONS IN SYMPTOMATIC COPD PATIENTS REGARDLESS OF BACKGROUND LAMA OR LABA THERAPY von SILER, THOMAS M, FOGARTY, CHARLES M, RHEAULT, TARA, BENGTSSON, THOMAS, ANN RICKARD, KATHLEEN

Volltext